Annual CFO
-$15.20 M
+$18.41 M+54.78%
31 December 2023
Summary:
10x Genomics annual cash flow from operations is currently -$15.20 million, with the most recent change of +$18.41 million (+54.78%) on 31 December 2023. During the last 3 years, it has risen by +$202.70 million (+93.03%). TXG annual CFO is now -143.89% below its all-time high of $34.63 million, reached on 31 December 2019.TXG Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$21.64 M
+$14.14 M+188.70%
30 September 2024
Summary:
10x Genomics quarterly cash flow from operations is currently $21.64 million, with the most recent change of +$14.14 million (+188.70%) on 30 September 2024. Over the past year, it has increased by +$46.95 million (+185.52%). TXG quarterly CFO is now -15.98% below its all-time high of $25.76 million, reached on 31 December 2023.TXG Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$39.17 M
+$46.95 M+603.79%
30 September 2024
Summary:
10x Genomics TTM cash flow from operations is currently $39.17 million, with the most recent change of +$46.95 million (+603.79%) on 30 September 2024. Over the past year, it has increased by +$66.40 million (+243.84%). TXG TTM CFO is now at all-time high.TXG TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXG Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +54.8% | +185.5% | +243.8% |
| 3 y3 years | +93.0% | +182.6% | +124.9% |
| 5 y5 years | +80.1% | +49.0% | +40.3% |
TXG Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +93.0% | -16.0% | +182.6% | at high | +124.9% |
| 5 y | 5 years | -143.9% | +93.0% | -16.0% | +116.6% | at high | +117.8% |
| alltime | all time | -143.9% | +93.0% | -16.0% | +116.6% | at high | +117.8% |
10x Genomics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $21.64 M(+188.7%) | $39.17 M(-603.8%) |
| June 2024 | - | $7.50 M(-147.7%) | -$7.78 M(-71.0%) |
| Mar 2024 | - | -$15.72 M(-161.0%) | -$26.80 M(+76.3%) |
| Dec 2023 | -$15.20 M(-54.8%) | $25.76 M(-201.8%) | -$15.20 M(-44.2%) |
| Sept 2023 | - | -$25.30 M(+119.5%) | -$27.23 M(+137.0%) |
| June 2023 | - | -$11.53 M(+179.4%) | -$11.49 M(-32.1%) |
| Mar 2023 | - | -$4.13 M(-130.1%) | -$16.93 M(-49.6%) |
| Dec 2022 | -$33.61 M(+57.2%) | $13.72 M(-243.5%) | -$33.61 M(-19.1%) |
| Sept 2022 | - | -$9.56 M(-43.6%) | -$41.52 M(-28.6%) |
| June 2022 | - | -$16.96 M(-18.5%) | -$58.18 M(+52.7%) |
| Mar 2022 | - | -$20.80 M(-458.3%) | -$38.09 M(+78.2%) |
| Dec 2021 | -$21.37 M | $5.80 M(-122.1%) | -$21.37 M(-86.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$26.22 M(-940.3%) | -$157.35 M(-15.7%) |
| June 2021 | - | $3.12 M(-176.4%) | -$186.77 M(-14.9%) |
| Mar 2021 | - | -$4.08 M(-96.9%) | -$219.40 M(+0.7%) |
| Dec 2020 | -$217.90 M(-729.3%) | -$130.18 M(+134.0%) | -$217.90 M(+168.9%) |
| Sept 2020 | - | -$55.63 M(+88.5%) | -$81.02 M(+645.5%) |
| June 2020 | - | -$29.52 M(+1045.9%) | -$10.87 M(-147.8%) |
| Mar 2020 | - | -$2.58 M(-138.4%) | $22.73 M(-34.3%) |
| Dec 2019 | $34.63 M(-145.3%) | $6.70 M(-53.9%) | $34.63 M(+24.0%) |
| Sept 2019 | - | $14.53 M(+255.8%) | $27.93 M(+108.4%) |
| June 2019 | - | $4.08 M(-56.2%) | $13.40 M(+43.8%) |
| Mar 2019 | - | $9.32 M | $9.32 M |
| Dec 2018 | -$76.41 M(+614.2%) | - | - |
| Dec 2017 | -$10.70 M | - | - |
FAQ
- What is 10x Genomics annual cash flow from operations?
- What is the all time high annual CFO for 10x Genomics?
- What is 10x Genomics annual CFO year-on-year change?
- What is 10x Genomics quarterly cash flow from operations?
- What is the all time high quarterly CFO for 10x Genomics?
- What is 10x Genomics quarterly CFO year-on-year change?
- What is 10x Genomics TTM cash flow from operations?
- What is the all time high TTM CFO for 10x Genomics?
- What is 10x Genomics TTM CFO year-on-year change?
What is 10x Genomics annual cash flow from operations?
The current annual CFO of TXG is -$15.20 M
What is the all time high annual CFO for 10x Genomics?
10x Genomics all-time high annual cash flow from operations is $34.63 M
What is 10x Genomics annual CFO year-on-year change?
Over the past year, TXG annual cash flow from operations has changed by +$18.41 M (+54.78%)
What is 10x Genomics quarterly cash flow from operations?
The current quarterly CFO of TXG is $21.64 M
What is the all time high quarterly CFO for 10x Genomics?
10x Genomics all-time high quarterly cash flow from operations is $25.76 M
What is 10x Genomics quarterly CFO year-on-year change?
Over the past year, TXG quarterly cash flow from operations has changed by +$46.95 M (+185.52%)
What is 10x Genomics TTM cash flow from operations?
The current TTM CFO of TXG is $39.17 M
What is the all time high TTM CFO for 10x Genomics?
10x Genomics all-time high TTM cash flow from operations is $39.17 M
What is 10x Genomics TTM CFO year-on-year change?
Over the past year, TXG TTM cash flow from operations has changed by +$66.40 M (+243.84%)